Obesity, hypertension, hyperlipidemia, obstructive sleep apnea, and hypothyroidism are independent metabolic risk factors ...
This retrospective, single‐center study included all patients aged 18 to 65 years who presented with ACS and underwent ...
Primary care case-finding for familial hypercholesterolemia in Poland: impressive genetic yield with key clarifications to e ...
Efficacy of Poly(ADP-ribose) Polymerase Inhibitors by Individual Genes in Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer: A US Food and Drug ...
Familial hypercholesterolemia (FH) is a common yet often underdiagnosed genetic condition that causes lifelong high LDL cholesterol and increases heart disease risk. Researchers have identified key ...
Recent studies and guideline updates are redefining how doctors approach cardiovascular risk, from established therapies like statins, ARBs, and ezetimibe to emerging targets such as lipoprotein(a).
Spread the loveIntroduction In recent months, the landscape surrounding the diabetes medication Ozempic and its related drugs has become increasingly contentious. As of April 2026, lawsuits alleging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results